Neos Therapeutics Garners $20,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=15b9460d-3c3f-453d-b691-9eedfdf8962d
Date
4/23/2014
Company Name
Neos Therapeutics
Mailing Address
2940 N Hwy 360 Grand Prairie, TX 75050 USA
Company Description
Neos Therapeutics is a specialty pharmaceutical company that focuses on time-release technologies. We have developed a broad, cutting-edge portfolio of processes that allow for tailored and independent release profiles of single and multiple ingredients.
Website
http://www.neostx.com
Transaction Type
Debt
Transaction Amount
$20,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The funds will support the Company’s efforts to obtain FDA approval of its three ADHD products, to expand the use of the proprietary controlled release technologies in the development of additional CR orally disintegrating tablet and CR liquid products, and to refinance its existing debt facility.
M&A Terms
Venture Investor